532296:BOM
Glenmark Pharmaceuticals Ltd
2 224,00 ₹
arrow_downward
-1,17%(-26,30) 1D
16 հոկ, 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
2 249,80 ₹
High
2 264,00 ₹
Low
2 224,00 ₹
Mkt. cap
628,43 մլրդ
Avg. vol.
17,97 հզր
Volume
12,94 հզր
Dividend
0,22%
Quarterly dividend
1,25 ₹
Ex-dividend date
03 հոկ, 2025 թ.
P/E ratio
34,92
52-wk high
2 536,85 ₹
52-wk low
1 794,00 ₹
EPS
63,68 ₹
Shares outstanding
0,00
No. of employees
17 հզր
Open
2 249,80 ₹
High
2 264,00 ₹
Low
2 224,00 ₹
Mkt. cap
628,43 մլրդ
Avg. vol.
17,97 հզր
Volume
12,94 հզր
Dividend
0,22%
Quarterly dividend
1,25 ₹
Ex-dividend date
03 հոկ, 2025 թ.
P/E ratio
34,92
52-wk high
2 536,85 ₹
52-wk low
1 794,00 ₹
EPS
63,68 ₹
Shares outstanding
0,00
No. of employees
17 հզր
News stories
From web sources and news partners
AskTraders.com
·
12 րոպե առաջ
S&P 500 Can Absorb Fed Hikes, Says UBS CIO After Hot US Inflation
Foreign Policy Journal
·
45 րոպե առաջ
Rigetti Computing (NASDAQ: RGTI) Stock Drops 21% In A Month As Quantum Sector Faces Commercialization Pressure
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd